Explainable Artificial Intelligence in Retinal Imaging for the detection of Systemic Diseases

Explainable Artificial Intelligence (AI) in the form of an interpretable and semiautomatic approach to stage grading ocular pathologies such as Diabetic retinopathy, Hypertensive retinopathy, and other retinopathies on the backdrop of major systemic diseases. The experimental study aims to evaluate an explainable staged grading process without using deep Convolutional Neural Networks (CNNs) directly. Many current CNN-based deep neural networks used for diagnosing retinal disorders might have appreciable performance but fail to pinpoint the basis driving their decisions. To improve these decisions' transparency, we have proposed a clinician-in-the-loop assisted intelligent workflow that performs a retinal vascular assessment on the fundus images to derive quantifiable and descriptive parameters. The retinal vessel parameters meta-data serve as hyper-parameters for better interpretation and explainability of decisions. The semiautomatic methodology aims to have a federated approach to AI in healthcare applications with more inputs and interpretations from clinicians. The baseline process involved in the machine learning pipeline through image processing techniques for optic disc detection, vessel segmentation, and arteriole/venule identification.

Machine learning based lens-free imaging technique for field-portable cytometry

Lens-free Shadow Imaging Technique (LSIT) is a well-established technique for the characterization of microparticles and biological cells. Due to its simplicity and cost-effectiveness, various low-cost solutions have been evolved, such as automatic analysis of complete blood count (CBC), cell viability, 2D cell morphology, 3D cell tomography, etc. The developed auto characterization algorithm so far for this custom-developed LSIT cytometer was based on the hand-crafted features of the cell diffraction patterns from the LSIT cytometer, that were determined from our empirical findings on thousands of samples of individual cell types, which limit the system in terms of induction of a new cell type for auto classification or characterization. Further, its performance is suffering from poor image (cell diffraction pattern) signatures due to its small signal or background noise. In this work, we address these issues by leveraging the artificial intelligence-powered auto signal enhancing scheme such as denoising autoencoder and adaptive cell characterization technique based on the transfer of learning in deep neural networks. The performance of our proposed method shows an increase in accuracy >98% along with the signal enhancement of >5 dB for most of the cell types, such as Red Blood Cell (RBC) and White Blood Cell (WBC). Furthermore, the model is adaptive to learn new type of samples within a few learning iterations and able to successfully classify the newly introduced sample along with the existing other sample types.